2021
DOI: 10.1111/codi.15949
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and determinants of depression up to 5 years after colorectal cancer surgery: results from the ColoREctal Wellbeing (CREW) study

Abstract: Aim: Depression experienced by people with colorectal cancer (CRC) is an important clinical problem affecting quality of life. Recognition of depression at key points in the pathway enables timely referral to support. This study aimed to examine depression before and 5 years after surgery to examine its prevalence and identify determinants. Method:The ColoREctal Wellbeing (CREW) study is a prospective UK cohort study involving 872 adults with nonmetastatic CRC recruited before surgery with curative intent.Ques… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 67 publications
(142 reference statements)
0
1
0
Order By: Relevance
“…frequency, irregularity, incontinence), fatigue, disrupted sleep, skin irritations, urinary problems, impact on relationships, informal and formal supportive healthcare needs, and financial and occupational challenges up to 5 years post-cancer treatment. Bowel dysfunction is experienced by as many as 79% of survivors 2 years post-treatment; 65% continue to have mobility problems, 40% report pain and discomfort 3 years post-treatment (Ju et al 2021), and 15% report depression 5 years after surgery (Calman et al 2021). Some require permanent or temporary stomas, which come with their own challenges (Rutherford et al 2020).…”
Section: Introductionmentioning
confidence: 99%
“…frequency, irregularity, incontinence), fatigue, disrupted sleep, skin irritations, urinary problems, impact on relationships, informal and formal supportive healthcare needs, and financial and occupational challenges up to 5 years post-cancer treatment. Bowel dysfunction is experienced by as many as 79% of survivors 2 years post-treatment; 65% continue to have mobility problems, 40% report pain and discomfort 3 years post-treatment (Ju et al 2021), and 15% report depression 5 years after surgery (Calman et al 2021). Some require permanent or temporary stomas, which come with their own challenges (Rutherford et al 2020).…”
Section: Introductionmentioning
confidence: 99%
“…This is probably a normal reaction when facing a cancer diagnosis and treatment including surgery, and the preoperative assessment was performed during a period of newly diagnosed disease and planned treatment with high impact, all this related to worrying, that is, a time of low HRQoL. It is not unusual with depression and even thoughts of suicide before comprehensive cancer surgery [21,22]. In clinical praxis, it can therefore be of value to use a screening instrument for depression to identify persons at risk.…”
Section: Discussionmentioning
confidence: 99%